First report of an intravenous and oral glycoprotein IIb/IIIa inhibitor (RPR 109891) in patients with recent acute coronary syndromes: results of the TIMI 15A and 15B trials - Giugliano, RP; McCabe, CH; Sequeira, RF; Frey, MJ; Henry, TD; Piana, RN; Tamby, JF; Jensen, BK; Nicolas, SB; Jennings, LK; Wise, RJ; Braunwald, E (Am Heart J, 2000)